ALC Stock Recent News

ALC LATEST HEADLINES

ALC Stock News Image - businesswire.com

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.

businesswire.com 2025 Apr 04
ALC Stock News Image - businesswire.com

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.

businesswire.com 2025 Apr 04
ALC Stock News Image - zacks.com

Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.

zacks.com 2025 Apr 03
ALC Stock News Image - businesswire.com

GENEVA--(BUSINESS WIRE)--Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter.

businesswire.com 2025 Apr 02
ALC Stock News Image - zacks.com

ALC, GKOS and REGN are well-positioned to benefit from the evolving space of cell-based ophthalmic therapy.

zacks.com 2025 Mar 31
ALC Stock News Image - zacks.com

Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

zacks.com 2025 Mar 28
ALC Stock News Image - businesswire.com

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LENSAR, Inc. (NasdaqCM: LNSR) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of LENSAR will receive $14.00 in cash, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash conditioned on achievement of a milestone, for each.

businesswire.com 2025 Mar 26
ALC Stock News Image - zacks.com

ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing visual outcomes with cutting-edge innovation.

zacks.com 2025 Mar 25
ALC Stock News Image - zacks.com

Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary Streamline software technology and LENSAR legacy laser system.

zacks.com 2025 Mar 25
ALC Stock News Image - businesswire.com

GENEVA--(BUSINESS WIRE)--Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities.

businesswire.com 2025 Mar 25
10 of 50